Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. is a large Shanghai Stock Exchange listed company dedicated to providing high-quality products and services for human health (stock code: 603567). The company focuses on the development direction of innovation and creation, high quality and high technology. Its business covers four major sectors: scientific and technological research and development, pharmaceutical industry, traditional Chinese medicine industry, and financial investment. It is one of the more innovative pharmaceutical companies in my country's pharmaceutical industry.

Zhenbaodao Pharmaceutical adheres to the development concept of "platform, cooperation, sharing, and win-win", and has gathered many outstanding leading talents at home and abroad. Through an open and diversified business model, it has created a "scientific and technological innovation as the driving force, and products + services as the The modern business pattern of two wings. We will also focus on the future development of my country's pharmaceutical industry, and will give back to the general public with more reliable products with high technological content and accurate efficacy, creating an international brand worthy of the trust and support of the people.

Zhenbaodao Pharmaceutical has been recognized as a national high-tech enterprise, Heilongjiang Provincial Enterprise Technology Center, a postdoctoral innovation and entrepreneurship practice base and a national postdoctoral research workstation. The company was the first to pass the five-star national standard certification for brand and after-sales service evaluation in the same industry across the country.

Zhenbaodao Pharmaceutical focuses on innovative research and development of three major product systems: traditional Chinese medicine, chemical medicine and biological medicine, adheres to the R&D strategy of "Chinese medicine as the main focus and Chinese and Western medicine as both emphasis", and builds a "one heart and four hospitals" R&D system. We have carried out in-depth cooperation with well-known universities, research institutions, CRO enterprises, etc., and formed a professional R&D team with R&D concepts in line with Europe and the United States.

The company insists on high-quality scientific and technological research and development as the core, builds a high-level R&D platform and high-tech product cluster, upgrades the product structure across the board, and greatly improves product output quantity and quality, providing new impetus for Zhenbao Island's innovation and creation development. Increase investment in R&D of biological drugs, chemical drugs and traditional Chinese medicines. In addition to oral solid preparations and injections, we also set up projects to study high-end preparations. The company's scientific research project layout reflects forward-looking and takes into account the optimization combination. At present, the company has 4 innovative chemical drugs projects under research and 39 generic chemical drugs projects. There is 1 innovative Chinese medicine project, 3 registered in-hospital preparations, 4 secondary development projects, and 3 protection projects for traditional Chinese medicine varieties.

After years of leapfrog development, Zhenbaodao Pharmaceutical has established a close marketing distribution network covering more than 30 provinces across the country and built a mature and complete marketing management service system. Through precise positioning of the segmented market and wide dissemination of brand academics, the quality of marketing services and continuous marketing empowerment can be continuously improved, and the market acceptance and expansion of various products can be realized, and product strength can be quickly transformed into sales strength, creating brand value and economic value.

While fully realizing standardized and efficient operations, Zhenbaodao Pharmaceutical regards cultural construction as a strong driving force for development. A corporate culture system is built with core values ​​as the spirit guided by multimedia communication as the means. Through the widespread dissemination of own media such as newspapers, television, websites, and WeChat platforms, as well as the holding of novel forms and participation in a wide range of employee cultural activities, we can effectively enhance cultural consensus and employee cohesion.

As a pioneer in actively expanding the development model of the new health industry, in the future, Zhenbaodao Pharmaceutical will provide the people with more systematic and better health services as its corporate development goal, and is committed to building it into a leading enterprise in China's new health industry. Let scientific and technological achievements benefit society more, make greater efforts and contributions to human health, and build a world-class brand!